148
148
Oct 6, 2015
10/15
by
CNBC
tv
eye 148
favorite 0
quote 0
off 19% for illumina. after the company said that weaker european and japanese markets are going to result in the company cutting sales guidance for the rest of the year. a quick check of the materials group. these are the stocks we'll be watching. dupont, providing the support to the support to the dow, up 39 points now. the company cutting guidance and upping cost cutting measures. freeport freeport-mcmore ran exploring energy alternatives. the dow up now 44 points. >> thank you, mary. let's get to the bond pits. rick santelli is at the cme group in chicago. good morning. >> good morning. even though you might look at rates and see we're only up a basis point or so, when you look at it in the context of a two-day market, really jumps out at you how much distance we've traveled in the last 24 hours on interest rates elope. alone. fed meeting, 917, there's so much talk about, you know, everything is doing well. the fed just doesn't want to upset the apple cart. the fed is in control of the apple cart. this
off 19% for illumina. after the company said that weaker european and japanese markets are going to result in the company cutting sales guidance for the rest of the year. a quick check of the materials group. these are the stocks we'll be watching. dupont, providing the support to the support to the dow, up 39 points now. the company cutting guidance and upping cost cutting measures. freeport freeport-mcmore ran exploring energy alternatives. the dow up now 44 points. >> thank you, mary....
78
78
Oct 6, 2015
10/15
by
KQED
tv
eye 78
favorite 0
quote 0
and the health technology company illumina warned investors of lower than expected revenue for the third fourth quarters. the firm blaming disappointing sales in europe and weakness in asia and the pacific region. that sent shares tumbling in initial after-hours trading as you see it fall off the cliff there. during the regular session the stock was off just a fraction at $163.17. >>> activist investors starboard value increasing its stake in the security company brinks. starboard is already the company's largest shareholder and hopes to turn around brinks' poor financial performance. brinks shares popped about 4 1/2% on the news, ending the day at $29.70. >>> the container store announcing earnings and revenue that missed revenue after the close. this as margins narrowed and expenses increased. shares were originally lower during after-hours trading and during the regular session the stock was up 3% to 15.57. >>> and the l.a. times is reporting that lionsgate and starz are in advanced merger talks. that combination would create a major media company. the two companies reportedly held hi
and the health technology company illumina warned investors of lower than expected revenue for the third fourth quarters. the firm blaming disappointing sales in europe and weakness in asia and the pacific region. that sent shares tumbling in initial after-hours trading as you see it fall off the cliff there. during the regular session the stock was off just a fraction at $163.17. >>> activist investors starboard value increasing its stake in the security company brinks. starboard is...
137
137
Oct 2, 2015
10/15
by
KQEH
tv
eye 137
favorite 0
quote 0
. >>> shares of the biotech company illumina slipped in today's session. the company's competitor peck bio came out with a faster cheaper version of one of its systems. the firm was also downgraded at lirink swan because of uncertainty of fits future products. shares there fell by 10 1/2% to 157.21. >>> performance food group making its market debut in today's session. the firm, which says it is the third largest food distributor by revenue in the country, offered 14.5 million shares at 19 bucks apiece. the company's ceo explains what's been driving business forward. >> the consumer's doing better. employment's getting better. what's particularly good for us is the two-income family. that's when eating out kind of goes from being discretionary to being a necessity. so we have a great outlook right now. >> shares rose 1% to $19.20. >>> experian announcing that one of its business units has been hacked, which has impacted t-mobile. the breach occurred on a server that contained data on behalf of t-mobile, since it's one of experian's clients. the data stolen
. >>> shares of the biotech company illumina slipped in today's session. the company's competitor peck bio came out with a faster cheaper version of one of its systems. the firm was also downgraded at lirink swan because of uncertainty of fits future products. shares there fell by 10 1/2% to 157.21. >>> performance food group making its market debut in today's session. the firm, which says it is the third largest food distributor by revenue in the country, offered 14.5 million...
163
163
Oct 6, 2015
10/15
by
CNBC
tv
eye 163
favorite 0
quote 0
then you are also getting a warning today from dna sequencing tool firm illumina. it says it has weak instrument sales, asia, another issue here. the transpacific partnership agreement has a limit on biopharma exclusivity. five years, half of what u.s. biopharma industry wanted. >> that is weighing on these drug makers. mandy. >> big time, indeed. thank you very much, bertha coombs. >>> as we mentioned, oil is rallying, the prices steady despite the market volatility. the worse may not be over. the other looming threat for oil companies coming your way. plus the new establishment. well, he's been compared to steve jobs and runs one of the world's top tech venture funds. he is the man behind air's bnb and drop box. we will get his next big idea. are you watching cnbc, first in business worldwide. mornings. wonderful, crazy mornings. we figure you probably don't have time to wait on hold. that's why at xfinity we're hard at work, building new apps like this one that lets you choose a time for us to call you. so instead of waiting on hold, we'll call you when things a
then you are also getting a warning today from dna sequencing tool firm illumina. it says it has weak instrument sales, asia, another issue here. the transpacific partnership agreement has a limit on biopharma exclusivity. five years, half of what u.s. biopharma industry wanted. >> that is weighing on these drug makers. mandy. >> big time, indeed. thank you very much, bertha coombs. >>> as we mentioned, oil is rallying, the prices steady despite the market volatility. the...
123
123
Oct 1, 2015
10/15
by
CNBC
tv
eye 123
favorite 0
quote 0
. >> biotech illumina down 10%. the worst performing stock in the biotech index. a competitor game out with a fast faster sequence. illumina cut to market perform from outperform based on uncertainty in the next generation is he queensing p generation sequencing products. >>> call it a commodity crunch. the index taking a hit so far this year down more than 15%, so as we kick off the fourth quarter, is there a turnaround in store. it's francisco blanch, thank you very much for joining us today. you have lots and lots of forecasts according to which commodity we're talking about. the one i really noticed was nat gas. you have a bullish call, 40% upside between now and the end of the year. is that predicated on a really freezing winter or something else you see? >> i think seasonally natural gas demand tends to pick up strongly into december and january, so we do see prices picking up seasonally. we think inventories will end up the injection season around 3.9 trillion cubic feet in storage, and again under normal weather conditions we think probably gas gets back a
. >> biotech illumina down 10%. the worst performing stock in the biotech index. a competitor game out with a fast faster sequence. illumina cut to market perform from outperform based on uncertainty in the next generation is he queensing p generation sequencing products. >>> call it a commodity crunch. the index taking a hit so far this year down more than 15%, so as we kick off the fourth quarter, is there a turnaround in store. it's francisco blanch, thank you very much for...